01652 福森藥業
按盘价 
1.290 0.000 (0.000%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | -0.942% | -14.624% | -2.693% | -2.673% | 1.342% |
| 股东资金回报率 (%) | -3.233% | -40.460% | -6.161% | -5.440% | 2.527% |
| 资本运用回报率 (%) | -3.047% | -40.536% | -5.341% | -5.509% | 2.219% |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 40.162% | 49.884% | 52.953% | 45.759% | 54.745% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 4.398% | -7.913% | 9.868% | 8.116% | 14.687% |
| 税前边际利润率 (%) | -2.781% | -58.414% | -5.206% | -6.303% | 6.169% |
| 纯利率 (%) | -4.311% | -57.904% | -6.414% | -7.037% | 4.316% |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 0.564 X | 0.595 X | 0.853 X | 0.850 X | 1.041 X |
| 速动比率 (X) | 0.452 X | 0.418 X | 0.610 X | 0.697 X | 0.792 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 71.671% | 70.249% | 58.160% | 54.610% | 46.992% |
| 总债项 / 总资产比率 (%) | 23.842% | 30.989% | 25.609% | 16.914% | 19.421% |
| 净债项 / 总资产比率 (%) | 17.206% | 29.288% | 23.015% | 7.426% | 12.880% |
| 总债项 / 股东资金比率 (%) | 83.850% | 103.793% | 61.065% | 37.185% | 36.569% |
| 长期债项 / 股东资金比率 (%) | 2.085% | 21.433% | 18.894% | 0.070% | 11.842% |
| 净债项 / 股东资金比率 (%) | 60.512% | 98.097% | 54.881% | 16.327% | 24.253% |
| 净现金 / (债项) ($) | (2.17亿) | (3.63亿) | (3.09亿) | (1.00亿) | (1.60亿) |
| 每股净现金 / (债项) ($) | (0.294) | (0.491) | (0.412) | (0.132) | (0.207) |
| 总债项 / 资本运用比率 (%) | 77.881% | 82.388% | 50.663% | 36.356% | 32.089% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | 3.886 X |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 262.345日 | 333.743日 | 186.797日 | 159.072日 | 237.637日 |
| 应收贸易帐周转率日数 (日) | 157.443日 | 166.452日 | 138.961日 | 150.218日 | 161.606日 |
| 应付贸易帐周转率日数 (日) | 181.340日 | 162.898日 | 106.852日 | 98.617日 | 99.705日 |
| 备注： | 实时报价更新时间为10/04/2026 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB -11,784 |
| 增长率 | -93.758% |
| 每股盈利/(亏损) | RMB -0.016 |
| 每股账面资产净值 (¥) | RMB 0.486 |